Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Zhe Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7335-3024; OpenAlex author ID A5115595442. Sources: OpenAlex.

Their work

Papers
12 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2015: 1 paper · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 1 paper

Papers 12

  1. Noninvasive prediction of Ki-67 expression in pancreatic cancer via contrast-enhanced ultrasound quantitative parameters: A diagnostic model study. Co-author DOI 10.4251/wjgo.v17.i6.107919↗
  2. Liver metastasis of pancreatic cancer: the new choice at the crossroads. Co-author DOI 10.21037/hbsn-22-489↗
  3. Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1112576↗
  4. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. Last author DOI 10.3748/wjg.v29.i3.579↗
  5. SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. Co-author DOI 10.7150/ijbs.64752↗
  6. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. First author DOI 10.1016/j.ejphar.2020.173225↗
  7. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1042/bsr20200214↗
  8. Inactivation of ATF-2 enhances epithelial-mesenchymal transition and gemcitabine sensitivity in human pancreatic cancer cells. First author DOI 10.1002/jcb.27734↗
  9. Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile. First author DOI 10.3892/mmr.2016.5007↗
  10. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Co-author DOI 10.3892/ol.2015.4042↗
  11. Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data. First author DOI 10.3892/ol.2016.4637↗
  12. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. Co-author DOI 10.3978/j.issn.1000-9604.2015.04.06↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingda Wu · 4 shared papers, 2016–2023 · strength 0.58
  2. Zhangyong Ren · 3 shared papers, 2020–2023 · strength 0.39
  3. Ren Lang · 3 shared papers, 2020–2023 · strength 0.39
  4. Jun-Hao Huang · 1 shared paper, 2023 · strength 0.31
  5. Ziyi Yang · 1 shared paper, 2025 · strength 0.30
  6. Liang Sang · 1 shared paper, 2025 · strength 0.30
  7. Lei Zhao · 1 shared paper, 2025 · strength 0.30
  8. Jin Long · 4 shared papers, 2015–2016 · strength 0.28
  9. Yuanhong Xu · 4 shared papers, 2015–2016 · strength 0.28
  10. Shaocheng Lyu · 2 shared papers, 2020–2023 · strength 0.28
  11. Xin Zhao · 2 shared papers, 2020 · strength 0.22
  12. Qiang He · 2 shared papers, 2020 · strength 0.22
  13. Qiang He · 1 shared paper, 2023 · strength 0.17
  14. Xin Zhao · 1 shared paper, 2023 · strength 0.17
  15. Fangfei Wang · 1 shared paper, 2023 · strength 0.17
  16. Chunlin Ge · 2 shared papers, 2016 · strength 0.15
  17. Shengyu Yang · 1 shared paper, 2022 · strength 0.15
  18. Yizhang Zhou · 1 shared paper, 2022 · strength 0.15
  19. Shuai Yuan · 1 shared paper, 2022 · strength 0.15
  20. Mingxiao Lang · 1 shared paper, 2022 · strength 0.15
  21. Song Gao · 1 shared paper, 2022 · strength 0.15
  22. Jihui Hao · 1 shared paper, 2022 · strength 0.15
  23. Chunlin Ge · 2 shared papers, 2015–2016 · strength 0.13
  24. Gang Ma · 1 shared paper, 2019 · strength 0.12
  25. Shaowei Song · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.